InnoCan Pharma (TSE:INNO) has released an update.
InnoCan Pharma celebrates the inclusion of its Scientific Advisory Board member, Dr. Joseph Pergolizzi, in Stanford University’s list of the top 2% most-cited scientists. His influential work in medical science and role in supporting InnoCan’s pharmaceutical R&D and FDA filings highlight his contribution to the company’s innovative healthcare solutions.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.
